Micro-X (ASX:MX1) is on track to launch its mobile x-ray unit, ‘DRX Revolution Nano’, after successfully passing the documentation review for the International Organization for Standardization (ISO).
The documentation review was a follow-up to the full ISO 13485 Stage Two Audit undertaken in mid-January 2017.
The auditor, BSI, has now recommended Micro-X for accreditation and the formal issue of the ISO 13485 accreditation certificate is expected within six weeks.
Micro-X designs, develops and manufactures a range of innovative, ultra-lightweight, mobile x-ray imaging systems for medical and security applications.
The competitive advantage of these miniaturised products stems from a new technology of electronic x-ray tube using carbon nano-tube (CNT) field emission devices.
The company has already established and is operating a quality management system for the design and manufacture of medical devices at its Tonsley facility in South Australia.
Micro-X’s ‘DRX Revolution Nano’ was recently featured at two important trade shows as part of the early marketing awareness campaign for the product.
The company held $5.6 million in cash at the end of the December 2016 quarter, representing a net increase of $2.7 million over the quarter.
Cash receipts during the quarter included $220,00 from project revenue under Micro-X’s current Australian Department of Defence contract and $8.2 million from an R&D tax incentive.